Jared Keller
@Kynam Capital Management, Lp
Latest period2024 - Q3ReportedManaged Assets$1.304BTotal holdings25
Assets growth rate0.63%Assets growth rate (2-Q avg)18.16%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Kynam Capital Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 25 positions.
Assets under management
The assets under management (AUM) of Kynam Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.304B in assets, with a quarterly growth rate of 0.63% and a 2-quarter average growth rate of 18.16%. The portfolio is managed by Jared Keller, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LQDALiquidia Corporation
| 1.74% | $22.663M 2.266M shares@ $10.0 avg price | Increased 147.27% |
IRWDIronwood Pharmaceuticals Inc
| 1.17% | $15.185M 3.686M shares@ $4.13 avg price | Increased 124.48% |
AMRNAmarin Corp Plc
| 0.6% | $7.783M 12.415M shares@ $0.63 avg price | Increased 2.13% |
STROSutro Biopharma Inc
| 0.55% | $7.15M 2.066M shares@ $3.47 avg price | Increased 2.12% |
CRBUCaribou Biosciences Inc
| 0.36% | $4.618M 2.356M shares@ $1.96 avg price | Increased 43.09% |
SLRNAcelyrin Inc
| 0.33% | $4.178M 847,366 shares@ $4.93 avg price | Increased 1.94% |
BNRBurning Rock Biotech Ltd
| 0.25% | $3.23M 989,217 shares@ $3.27 avg price | Increased 1.5% |